Dyadic International, Inc. (DYAI) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good evening and welcome to Dyadic International's Q2 2026 conference call. Currently, all participants are in the listen-only mode. Following management's prepared remarks, there will be a brief question and answer session. As a reminder, this conference call is being recorded today, August 12th, 2026. I would now like to turn the call over to Ms. Ping Rawson, Dyadic's Chief Financial Officer. Please go ahead. Thank you. Good evening and welcome everyone to DIATIC's second quarter 2026 conference call. I hope you have had the opportunity to review DIATIC's press releases announcing financial results for the quarter ended June 30, 2026. You may access our release and form 10-Q under the investor session of the company's website at diatic.com. On today's call, our President and Chief Operating Officer, Joe Hazelton, will review our Q2 2026 business and corporate highlights and provide commentary on the strategic direction of the business. Our CEO, Mark Emalfarb, will provide an update on our biopharmaceutical program, and I will follow with a review of our financial results in more detail, after which we will hold a brief question and answer session. At this time, I would like to inform you that certain commentary made in this conference call may be considered forward-looking statements, which involve risks and uncertainties and other factors that could cause DIATIC's actual results, performance, scientific or otherwise, or achievements to be materially different from those expressed or implied by these forward-looking statements. DIATIC expressly disclaims any duty to provide updates to its forward-looking statements. whether because of new information, future events, or otherwise. Participants are directed to the risk factors set forth in DIATIC's report filed with ...